We are live on ! Find out more
EI

EAM Investors Portfolio holdings

AUM $866M
1-Year Est. Return 377.14%
This Fund
S&P 500
This Quarter Est. Return
+113.09%
1 Year Est. Return
+377.14%
3 Year Est. Return
+5,228.32%
5 Year Est. Return
+49,813.07%
10 Year Est. Return
+19,957,621.5%
AUM
$452M
AUM Growth
+$130M
Cap. Flow
-$18.5M
Cap. Flow %
-4.08%
Top 10 Hldgs %
10.66%
Holding
352
New
147
Increased
15
Reduced
84
Closed
97

Top Buys

Rank Stock Value
1
AWH
Aspira Women's Health Inc. Common Stock
AWH
+$3.03M
2
OSPN icon
OneSpan
OSPN
+$2.96M
3
ATEX icon
Anterix
ATEX
+$2.79M
4
CALX icon
Calix
CALX
+$2.73M
5
GNMK
GenMark Diagnostics, Inc
GNMK
+$2.72M

Top Sells

Rank Stock Value
1
AXSM icon
Axsome Therapeutics
AXSM
+$3.54M
2
KPTI icon
Karyopharm Therapeutics
KPTI
+$3.44M
3
TDOC icon
Teladoc Health
TDOC
+$3.2M
4
KRYS icon
Krystal Biotech
KRYS
+$3M
5
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.95M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 21.89%
3 Consumer Discretionary 16.2%
4 Industrials 10.05%
5 Consumer Staples 6.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UFPT icon
326
UFP Technologies
UFPT
$2.41B
– –
-30,097
Closed -$1.15M
VCTR icon
327
Victory Capital Holdings
VCTR
$6.57B
– –
-78,250
Closed -$1.28M
VRNS icon
328
Varonis Systems
VRNS
$4.87B
– –
-76,395
Closed -$1.62M
VSTM icon
329
Verastem
VSTM
$519M
– –
-18,147
Closed -$575K
VVX icon
330
V2X
VVX
$2.65B
– –
-29,123
Closed -$1.21M
WDFC icon
331
WD-40
WDFC
$3.1B
– –
-8,523
Closed -$1.71M
WMS icon
332
Advanced Drainage Systems
WMS
$11.4B
– –
-28,777
Closed -$847K
XOMA
333
DELISTED
Xoma
XOMA
– –
-39,609
Closed -$806K
SUNE
334
SUNation Energy
SUNE
$10.2M
– –
0
– -$526K
LGTY
335
DELISTED
Logility Supply Chain Solutions, Inc. Common Stock
LGTY
– –
-120,910
Closed -$1.72M
NVRO
336
DELISTED
NEVRO CORP.
NVRO
– –
-16,288
Closed -$1.63M
INFN
337
DELISTED
Infinera Corporation Common Stock
INFN
– –
-389,369
Closed -$2.06M
NSTG
338
DELISTED
NanoString Technologies, Inc.
NSTG
– –
-74,485
Closed -$1.79M
PCTI
339
DELISTED
PCTEL, Inc. Common Stock
PCTI
– –
-311,493
Closed -$2.07M
AEY
340
DELISTED
ADDvantage Technologies Group
AEY
– –
-14,714
Closed -$324K
RETA
341
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
– –
-11,779
Closed -$1.7M
BLU
342
DELISTED
BELLUS Health Inc.
BLU
– –
-72,811
Closed -$727K
SEAC
343
DELISTED
Seachange International Inc
SEAC
– –
-33,025
Closed -$2.46M
LHCG
344
DELISTED
LHC Group LLC
LHCG
– –
-17,444
Closed -$2.45M
RADA
345
DELISTED
Rada Electronic Industries Ltd
RADA
– –
-174,137
Closed -$609K
GBT
346
DELISTED
Global Blood Therapeutics, Inc.
GBT
– –
-23,126
Closed -$1.18M
EPZM
347
DELISTED
Epizyme, Inc
EPZM
– –
-67,810
Closed -$1.05M
LMNX
348
DELISTED
Luminex Corp
LMNX
– –
-60,086
Closed -$1.65M
EIDX
349
DELISTED
Eidos Therapeutics, Inc. Common Stock
EIDX
– –
-55,532
Closed -$2.72M
PFNX
350
DELISTED
Pfenex Inc.
PFNX
– –
-253,077
Closed -$2.23M
11 12 13
14
15

Similar funds

RWM
RMG Wealth Management Platteville, Wisconsin $866M AUM 11.95% 1-Year Est. Return
MCM
Makena Capital Management Menlo Park, California $866M AUM 17.79% 1-Year Est. Return
HP
Havemeyer Place Greenwich, Connecticut $867M AUM
OMG
One Madison Group New York $866M AUM 33.81% 1-Year Est. Return
ICCFIA
IDG China Capital Fund III Associates Central Hong Kong, China $868M AUM 24.3% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $863M AUM
WCM
Wallace Capital Management Dallas, Texas $871M AUM 13.69% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

EAM Investors's Q2 2020 Portfolio in Review

As of Q2 2020, EAM Investors held 352 positions worth $452M, up 40% from $322M the previous quarter. Its ten largest holdings account for 11% of the portfolio.

EAM Investors withdrew a net $18.5M in Q2 2020, closing 97 positions and reducing 84 holdings. Its most notable exit was Karyopharm Therapeutics, an estimated $3.44M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 40% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, EAM Investors opened a new position in Aspira Women's Health Inc. Common Stock worth $2.61M.

  • EAM Investors's largest Q2 2020 buy was Aspira Women's Health Inc. Common Stock: 45,313 shares worth $2.61M.
  • EAM Investors added most to Purple Innovation in Q2 2020, an estimated $2.04M increase.
  • EAM Investors's biggest Q2 2020 reduction was Axsome Therapeutics, cutting an estimated $3.54M.
  • EAM Investors fully exited Karyopharm Therapeutics in Q2 2020, selling an estimated $3.44M.
  • EAM Investors's ten largest holdings make up 11% of its $452M portfolio in Q2 2020.
  • EAM Investors opened 147 new positions and closed 97 in Q2 2020.
  • EAM Investors's portfolio value rose 40% quarter-over-quarter to $452M.

Based on EAM Investors's 13F filing for Q2 2020, filed 13 Aug 2020.